Lower-dose blood thinner after heart attack stent
Part of Heart & circulation clinical trials.
This trial looks at whether switching to a “lower-intensity” blood thinner plan after a heart attack and stent is safer and still works well. It may help reduce bleeding risk compared with a stronger approach, while protecting the stent from clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old.
- You had an acute heart attack, and you already got a stent placed through PCI (a procedure to open blocked arteries).
- Your stent type matches this study’s specific stent: Orsiro ultrathin bioresorbable polymer sirolimus-eluting stent.
- You can sign informed consent (or you have a legal representative who can).
- You do not have a history of bleeding in the brain (hemorrhagic stroke or ICH).
- You are not having active bleeding and you do not have a high bleeding risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether taking just one blood-thinning medicine (instead of two) after a stent procedure helps prevent future heart problems while lowering the risk of bleeding. It's for people who recently had a heart attack or unstable chest pain and had a stent placed.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
This Phase 4 study tests whether using a reduced blood-thinner (antithrombotic) strategy after a heart attack can lower bleeding without losing heart protection. It is mainly for people considered high risk for bleeding after getting a stent.
This trial tests whether choosing a shorter blood thinner treatment based on your genes, or reducing the dose, is safe and works well for people with high bleeding risk after getting a stent for a heart attack or chest pain.
This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.
This trial looks at whether using heart imaging (OCT or angiogram) to guide how long you take two blood thinners after a heart attack (STEMI) can be safe and effective. If you qualify, your doctor may be able to reduce your blood thinner use sooner, which could lower bleeding risk while still protecting your heart.
Hear when a new Acute Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.